Amenamevir - CISMeF

Preferred Label : Amenamevir;

NCIt definition : A novel helicase-primase inhibitor that is active against varicella-zoster virus and herpes simplex virus types 1 and 2. Amenamenir stabilizes the interaction between the helicase-primase and its DNA substrates, preventing the progression through helicase or primase catalytic cycles, thus interfering with viral DNA replication and viral growth.;

UNII : 94X46KW4AE;

InChIKey : MNHNIVNAFBSLLX-UHFFFAOYSA-N;

CAS number : 841301-32-4;

Molecule name : ASP 2151; ASP2151;

Chemical formula : C24H26N4O5S;

Details

Origin ID

C90782;

UMLS CUI

C2983876;

Automatic exact mappings (from CISMeF team)
- Amenamevir [ICD-11 Extension code]
Currated CISMeF NLP mapping
- amenamevir [MeSH concept]
See also inter- (CISMeF)
- ASP2151 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- amenamevir [MeSH concept]
- amenamevir [ATC Code]
Validated automatic mappings to BTNT
- amenamevir [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients